{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:32:53Z","timestamp":1787315573053,"version":"build-2736575974"},"reference-count":138,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s40256-026-00810-y","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T11:21:39Z","timestamp":1784200899000},"page":"537-557","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Using Artificial Intelligence to Identify Patterns and Predictors of Adverse Drug Reactions in Cardiovascular Patients: A Comprehensive Narrative Review"],"prefix":"10.1007","volume":"26","author":[{"given":"Erfan","family":"Shahabinejad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Soflaei-Shahrbabak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzieh","family":"Gholami Shoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Azhdarimoghaddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Mozafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pouya","family":"Yektaee-Rad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar","family":"Monajemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayan","family":"Ghanouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhao","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mani","family":"Khorsand Askari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"810_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-019-4651-7","volume":"20","author":"H Khalil","year":"2020","unstructured":"Khalil H, Huang C. Adverse drug reactions in primary care: a scoping review. BMC Health Serv Res. 2020;20:1\u201313.","journal-title":"BMC Health Serv Res"},{"key":"810_CR2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/anae.14143","volume":"73","author":"K Patton","year":"2018","unstructured":"Patton K, Borshoff D. Adverse drug reactions. Anaesthesia. 2018;73:76\u201384.","journal-title":"Anaesthesia"},{"key":"810_CR3","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00228-013-1630-5","volume":"70","author":"C Pedr\u00f3s","year":"2014","unstructured":"Pedr\u00f3s C, Quintana B, Rebolledo M, Porta N, Vallano A, Arnau JM. Prevalence, risk factors and main features of adverse drug reactions leading to hospital admission. Eur J Clin Pharmacol. 2014;70:361\u20137.","journal-title":"Eur J Clin Pharmacol"},{"key":"810_CR4","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s40264-016-0444-7","volume":"39","author":"MT Angamo","year":"2016","unstructured":"Angamo MT, Chalmers L, Curtain CM, Bereznicki LR. Adverse-drug-reaction-related hospitalisations in developed and developing countries: a review of prevalence and contributing factors. Drug Saf. 2016;39:847\u201357.","journal-title":"Drug Saf"},{"issue":"4","key":"810_CR5","first-page":"241","volume":"10","author":"Y Farida","year":"2021","unstructured":"Farida Y, Tsalatsatun KF. Adverse drug reactions study of antihypertensive drugs in primary care settings. J Manaj DAN PELAYANAN Farm [J Manag Pharm Pract]. 2021;10(4):241\u20138.","journal-title":"J Manaj DAN PELAYANAN Farm [J Manag Pharm Pract]."},{"issue":"736","key":"810_CR6","doi-asserted-by":"publisher","first-page":"e832","DOI":"10.3399\/BJGP.2023.0153","volume":"73","author":"WN Insani","year":"2023","unstructured":"Insani WN, Whittlesea C, Ju C, Man KK, Adesuyan M, Chapman S, et al. Impact of ACEIs and ARBs-related adverse drug reaction on patients\u2019 clinical outcomes: a cohort study in UK primary care. Br J Gen Pract. 2023;73(736):e832\u201342.","journal-title":"Br J Gen Pract"},{"key":"810_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-021-07157-3","author":"NM Patel","year":"2022","unstructured":"Patel NM, Stottlemyer BA, Gray MP, Boyce RD, Kane-Gill SL. A pharmacovigilance study of adverse drug reactions reported for cardiovascular disease medications approved between 2012 and 2017 in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) database. Cardiovasc Drugs Ther. 2022. https:\/\/doi.org\/10.1007\/s10557-021-07157-3.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"1","key":"810_CR8","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1186\/s12872-022-02937-7","volume":"22","author":"EA Shegena","year":"2022","unstructured":"Shegena EA, Nigussie KA, Tamukong R, Lumori BAE, Yadesa TM. Prevalence and factors associated with adverse drug reactions among heart failure patients hospitalized at Mbarara Regional Referral Hospital, Uganda. BMC Cardiovasc Disord. 2022;22(1):480.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"810_CR9","first-page":"51","volume":"6","author":"K Gholami","year":"2008","unstructured":"Gholami K, Ziaie S, Shalviri G. Adverse drug reactions induced by cardiovascular drugs in outpatients. Pharm Pract (Internet). 2008;6(1):51\u20135.","journal-title":"Pharm Pract (Internet)."},{"issue":"6","key":"810_CR10","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1093\/ageing\/afaa188","volume":"49","author":"EL Jennings","year":"2020","unstructured":"Jennings EL, Murphy KD, Gallagher P, O\u2019Mahony D. In-hospital adverse drug reactions in older adults; prevalence, presentation and associated drugs\u2014a systematic review and meta-analysis. Age Ageing. 2020;49(6):948\u201358.","journal-title":"Age Ageing"},{"key":"810_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab347","author":"Y Noguchi","year":"2021","unstructured":"Noguchi Y, Tachi T, Teramachi H. Detection algorithms and attentive points of safety signal using spontaneous reporting systems as a clinical data source. Brief Bioinform. 2021. https:\/\/doi.org\/10.1093\/bib\/bbab347.","journal-title":"Brief Bioinform"},{"key":"810_CR12","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s40264-018-00794-y","volume":"42","author":"C McMaster","year":"2019","unstructured":"McMaster C, Liew D, Keith C, Aminian P, Frauman A. A machine-learning algorithm to optimise automated adverse drug reaction detection from clinical coding. Drug Saf. 2019;42:721\u20135.","journal-title":"Drug Saf"},{"key":"810_CR13","doi-asserted-by":"crossref","unstructured":"Pourebrahim B, Keyvanpour M, editors. Adverse drug reaction detection using data mining techniques: a review article. In: 2020 10th International Conference on Computer and Knowledge Engineering (ICCKE). IEEE; 2020.","DOI":"10.1109\/ICCKE50421.2020.9303709"},{"key":"810_CR14","doi-asserted-by":"publisher","unstructured":"Das P, Mazumder DH. An extensive survey on the use of supervised machine learning techniques in the past two decades for prediction of drug side effects. Artif Intell Rev. 2023;56(9):9809\u201336. https:\/\/doi.org\/10.1007\/s10462-023-10413-7.","DOI":"10.1007\/s10462-023-10413-7"},{"issue":"10","key":"810_CR15","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s40264-014-0218-z","volume":"37","author":"R Harpaz","year":"2014","unstructured":"Harpaz R, Callahan A, Tamang S, Low Y, Odgers D, Finlayson S, et al. Text mining for adverse drug events: the promise, challenges, and state of the art. Drug Saf. 2014;37(10):777\u201390.","journal-title":"Drug Saf"},{"key":"810_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/children9121826","author":"N Yal\u00e7\u0131n","year":"2022","unstructured":"Yal\u00e7\u0131n N, Ka\u015f\u0131kc\u0131 M, \u00c7elik HT, Allegaert K, Demirkan K, Yi\u011fit \u015e, et al. An artificial intelligence approach to support detection of neonatal adverse drug reactions based on severity and probability scores: a new risk score as web-tool. Children (Basel). 2022. https:\/\/doi.org\/10.3390\/children9121826.","journal-title":"Children (Basel)"},{"issue":"1","key":"810_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41073-019-0064-8","volume":"4","author":"C Baethge","year":"2019","unstructured":"Baethge C, Goldbeck-Wood S, Mertens S. SANRA\u2014a scale for the quality assessment of narrative review articles. Res Integr Peer Rev. 2019;4(1):5.","journal-title":"Res Integr Peer Rev."},{"issue":"10","key":"810_CR18","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s40264-017-0572-8","volume":"40","author":"A Santoro","year":"2017","unstructured":"Santoro A, Genov G, Spooner A, Raine J, Arlett P. Promoting and protecting public health: how the European Union Pharmacovigilance System works. Drug Saf. 2017;40(10):855\u201369.","journal-title":"Drug Saf"},{"issue":"7","key":"810_CR19","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.drudis.2019.03.003","volume":"24","author":"CY Lee","year":"2019","unstructured":"Lee CY, Chen YP. Machine learning on adverse drug reactions for pharmacovigilance. Drug Discov Today. 2019;24(7):1332\u201343.","journal-title":"Drug Discov Today"},{"issue":"12","key":"810_CR20","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1016\/j.clinthera.2018.07.012","volume":"40","author":"P Beninger","year":"2018","unstructured":"Beninger P. Pharmacovigilance: an overview. Clin Ther. 2018;40(12):1991\u20132004.","journal-title":"Clin Ther"},{"key":"810_CR21","unstructured":"Organization WH. WHO Policy perspectives on medicines. Looking at the pharmacovigilance: ensuring the safe use of medicines. Geneva: World Health Organization. Published October 2004. Available from: http:\/\/apps.who.int\/medicinedocs\/pdf\/s6164e\/s6164e.pdf. Accessed 15 Dec 2009."},{"issue":"2","key":"810_CR22","first-page":"109","volume":"33","author":"R Mockute","year":"2019","unstructured":"Mockute R, Desai S, Perera S, Assuncao B, Danysz K, Tetarenko N, et al. Artificial intelligence within pharmacovigilance: a means to identify cognitive services and the framework for their validation. Pharmaceut Med. 2019;33(2):109\u201320.","journal-title":"Pharmaceut Med."},{"key":"810_CR23","unstructured":"US Food and Drug Administration. Questions and answers on FDA\u2019s Adverse Event Reporting System (FAERS) 2018. Available from: https:\/\/www.fda.gov\/drugs\/surveillance\/questions-and-answers-fdas-adverseevent-reporting-system-faers. Accessed 13 Dec 2019."},{"issue":"12","key":"810_CR24","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431x20165646","volume":"49","author":"EL Andrade","year":"2016","unstructured":"Andrade EL, Bento AF, Cavalli J, Oliveira SK, Schwanke RC, Siqueira JM, et al. Non-clinical studies in the process of new drug development\u2014Part II: good laboratory practice, metabolism, pharmacokinetics, safety and dose translation to clinical studies. Braz J Med Biol Res. 2016;49(12):e5646.","journal-title":"Braz J Med Biol Res"},{"key":"810_CR25","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.2147\/DDDT.S424991","volume":"17","author":"SK Niazi","year":"2023","unstructured":"Niazi SK. The coming of age of AI\/ML in drug discovery, development, clinical testing, and manufacturing: the FDA perspectives. Drug Des Dev Ther. 2023;17:2691\u2013725.","journal-title":"Drug Des Dev Ther"},{"key":"810_CR26","volume-title":"Safety of medicines: a guide to detecting and reporting adverse drug reactions\u2014why health professionals need to take action","author":"World Health Organization","year":"2002","unstructured":"World Health Organization. Safety of medicines: a guide to detecting and reporting adverse drug reactions\u2014why health professionals need to take action. Geneva: World Health Organization; 2002."},{"key":"810_CR27","unstructured":"US Food and Drug Administration. Questions and answers on FDA\u2019s Adverse Event Reporting System (FAERS) 2019. Available from: https:\/\/www.fda.gov\/drugs\/surveillance\/fda-adverse-event-reporting-system-faers."},{"issue":"5","key":"810_CR28","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1177\/009286150804200501","volume":"42","author":"M Lindquist","year":"2008","unstructured":"Lindquist M. VigiBase, the WHO Global ICSR Database System: basic facts. Drug Inf J DIJ\/Drug Inf Assoc. 2008;42(5):409\u201319.","journal-title":"Drug Inf J DIJ\/Drug Inf Assoc."},{"issue":"D1","key":"810_CR29","doi-asserted-by":"publisher","first-page":"D1075","DOI":"10.1093\/nar\/gkv1075","volume":"44","author":"M Kuhn","year":"2016","unstructured":"Kuhn M, Letunic I, Jensen LJ, Bork P. The SIDER database of drugs and side effects. Nucleic Acids Res. 2016;44(D1):D1075\u20139.","journal-title":"Nucleic Acids Res"},{"issue":"e1","key":"810_CR30","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1136\/amiajnl-2011-000699","volume":"19","author":"M Liu","year":"2012","unstructured":"Liu M, Wu Y, Chen Y, Sun J, Zhao Z, Chen XW, et al. Large-scale prediction of adverse drug reactions using chemical, biological, and phenotypic properties of drugs. J Am Med Inform Assoc. 2012;19(e1):e28-35.","journal-title":"J Am Med Inform Assoc"},{"key":"810_CR31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.artmed.2017.01.004","volume":"76","author":"R Cai","year":"2017","unstructured":"Cai R, Liu M, Hu Y, Melton BL, Matheny ME, Xu H, et al. Identification of adverse drug-drug interactions through causal association rule discovery from spontaneous adverse event reports. Artif Intell Med. 2017;76:7\u201315.","journal-title":"Artif Intell Med"},{"issue":"1","key":"810_CR32","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1038\/s41598-018-19979-7","volume":"8","author":"C Xiao","year":"2018","unstructured":"Xiao C, Li Y, Baytas IM, Zhou J, Wang F. An MCEM Framework for drug safety signal detection and combination from heterogeneous real world evidence. Sci Rep. 2018;8(1):1806.","journal-title":"Sci Rep"},{"issue":"12","key":"810_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0266435","volume":"17","author":"YH Chen","year":"2022","unstructured":"Chen YH, Shih YT, Chien CS, Tsai CS. Predicting adverse drug effects: a heterogeneous graph convolution network with a multi-layer perceptron approach. PLoS ONE. 2022;17(12):e0266435.","journal-title":"PLoS ONE"},{"issue":"1","key":"810_CR34","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12911-017-0483-8","volume":"17","author":"Y Wang","year":"2017","unstructured":"Wang Y, Coiera E, Runciman W, Magrabi F. Using multiclass classification to automate the identification of patient safety incident reports by type and severity. BMC Med Inform Decis Mak. 2017;17(1):84.","journal-title":"BMC Med Inform Decis Mak"},{"issue":"6","key":"810_CR35","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1093\/jamia\/ocv102","volume":"22","author":"G Wang","year":"2015","unstructured":"Wang G, Jung K, Winnenburg R, Shah NH. A method for systematic discovery of adverse drug events from clinical notes. J Am Med Inform Assoc. 2015;22(6):1196\u2013204.","journal-title":"J Am Med Inform Assoc"},{"issue":"Suppl 2","key":"810_CR36","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12911-016-0311-6","volume":"16","author":"J Zhao","year":"2016","unstructured":"Zhao J, Henriksson A. Learning temporal weights of clinical events using variable importance. BMC Med Inform Decis Mak. 2016;16(Suppl 2):71.","journal-title":"BMC Med Inform Decis Mak"},{"issue":"6","key":"810_CR37","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12918-018-0624-4","volume":"12","author":"L Liu","year":"2018","unstructured":"Liu L, Yu Y, Fei Z, Li M, Wu F-X, Li H-D, et al. An interpretable boosting model to predict side effects of analgesics for osteoarthritis. BMC Syst Biol. 2018;12(6):105.","journal-title":"BMC Syst Biol"},{"issue":"5","key":"810_CR38","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s40264-022-01155-6","volume":"45","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Yu Y, Wang H, Li Y, Deng Y, Jiang G, et al. Machine learning in causal inference: application in pharmacovigilance. Drug Saf. 2022;45(5):459\u201376.","journal-title":"Drug Saf"},{"key":"810_CR39","doi-asserted-by":"crossref","unstructured":"Kroeze JH, Matthee MC, Bothma TJ, editors. Differentiating data-and text-mining terminology. In: Proceedings of the 2003 annual research conference of the South African Institute of Computer Scientists and Information Technologists on Enablement through Technology; 2003.","DOI":"10.4102\/sajim.v6i4.353"},{"key":"810_CR40","doi-asserted-by":"crossref","unstructured":"McMaster C, Chan J, Liew DF, Su E, Frauman AG, Chapman WW, Pires DE. Developing a deep learning natural language processing algorithm for automated reporting of adverse drug reactions. medRxiv. 2021:2021.12.11.21267504.","DOI":"10.1101\/2021.12.11.21267504"},{"key":"810_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12859-019-3053-5","volume":"20","author":"T Zhang","year":"2019","unstructured":"Zhang T, Lin H, Ren Y, Yang L, Xu B, Yang Z, et al. Adverse drug reaction detection via a multihop self-attention mechanism. BMC Bioinform. 2019;20:1\u201311.","journal-title":"BMC Bioinform"},{"issue":"4","key":"810_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1145\/2719920","volume":"47","author":"S Karimi","year":"2015","unstructured":"Karimi S, Wang C, Metke-Jimenez A, Gaire R, Paris C. Text and data mining techniques in adverse drug reaction detection. ACM Comput Surv (CSUR). 2015;47(4):1\u201339.","journal-title":"ACM Comput Surv (CSUR)."},{"issue":"1","key":"810_CR43","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27\u201330.","journal-title":"Nucleic Acids Res"},{"key":"810_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2013.47","author":"P LePendu","year":"2013","unstructured":"LePendu P, Iyer S, Bauer-Mehren A, Harpaz R, Mortensen J, Podchiyska T, et al. Pharmacovigilance using clinical notes. Clin Pharmacol Ther. 2013. https:\/\/doi.org\/10.1038\/clpt.2013.47.","journal-title":"Clin Pharmacol Ther"},{"key":"810_CR45","doi-asserted-by":"crossref","unstructured":"Lin C, Hsu CJ, Lou YS, Yeh SJ, Lee CC, Su SL, et al. Artificial intelligence learning semantics via external resources for classifying diagnosis codes in discharge notes. J Med Internet Res. 2017;19(11):e380.","DOI":"10.2196\/jmir.8344"},{"issue":"1","key":"810_CR46","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/s41598-017-00908-z","volume":"7","author":"S Jamal","year":"2017","unstructured":"Jamal S, Goyal S, Shanker A, Grover A. Predicting neurological adverse drug reactions based on biological, chemical and phenotypic properties of drugs using machine learning models. Sci Rep. 2017;7(1):872.","journal-title":"Sci Rep"},{"issue":"1","key":"810_CR47","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/s12859-015-0774-y","volume":"16","author":"W Zhang","year":"2015","unstructured":"Zhang W, Liu F, Luo L, Zhang J. Predicting drug side effects by multi-label learning and ensemble learning. BMC Bioinform. 2015;16(1):365.","journal-title":"BMC Bioinform"},{"issue":"1","key":"810_CR48","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12967-019-1918-z","volume":"17","author":"S Jamal","year":"2019","unstructured":"Jamal S, Ali W, Nagpal P, Grover S, Grover A. Computational models for the prediction of adverse cardiovascular drug reactions. J Transl Med. 2019;17(1):171.","journal-title":"J Transl Med"},{"issue":"1","key":"810_CR49","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s41512-025-00197-5","volume":"9","author":"SI Mozumder","year":"2025","unstructured":"Mozumder SI, Booth S, Riley RD, Rutherford MJ, Lambert PC. Calibration of cause-specific absolute risk for external validation using each cause-specific hazards model in the presence of competing events. Diagn Progn Res. 2025;9(1):23.","journal-title":"Diagn Progn Res."},{"key":"810_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11162244","author":"D Piovani","year":"2023","unstructured":"Piovani D, Sokou R, Tsantes AG, Vitello AS, Bonovas S. Optimizing clinical decision making with decision curve analysis: insights for clinical investigators. Healthcare (Basel). 2023. https:\/\/doi.org\/10.3390\/healthcare11162244.","journal-title":"Healthcare (Basel)"},{"issue":"1","key":"810_CR51","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/pds.5548","volume":"32","author":"A Coste","year":"2023","unstructured":"Coste A, Wong A, Bokern M, Bate A, Douglas IJ. Methods for drug safety signal detection using routinely collected observational electronic health care data: a systematic review. Pharmacoepidemiol Drug Saf. 2023;32(1):28\u201343.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"810_CR52","doi-asserted-by":"publisher","unstructured":"Haas SW, Travers D, Waller A, Mahalingam D, Crouch J, Schwartz TA, et al. Emergency medical text classifier: new system improves processing and classification of triage notes. Online J Public Health Inform. 2014;6(2):e178. https:\/\/doi.org\/10.5210\/ojphi.v6i2.5469.","DOI":"10.5210\/ojphi.v6i2.5469"},{"key":"810_CR53","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7594","volume":"350","author":"GS Collins","year":"2015","unstructured":"Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ. 2015;350:g7594.","journal-title":"BMJ"},{"issue":"3","key":"810_CR54","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1056\/NEJMc2104626","volume":"385","author":"SG Finlayson","year":"2021","unstructured":"Finlayson SG, Subbaswamy A, Singh K, Bowers J, Kupke A, Zittrain J, et al. The clinician and dataset shift in artificial intelligence. N Engl J Med. 2021;385(3):283\u20136.","journal-title":"N Engl J Med"},{"key":"810_CR55","doi-asserted-by":"publisher","DOI":"10.2174\/1574886313666181026100000","author":"US Food and Drug Adminstration","year":"2019","unstructured":"US Food and Drug Adminstration. Novel adverse events of iloperidone: a disproportionality analysis in US Food and Drug Administration Adverse Event Reporting System (FAERS) database. Curr Drug Saf. 2019. https:\/\/doi.org\/10.2174\/1574886313666181026100000.","journal-title":"Curr Drug Saf"},{"issue":"1","key":"810_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sdata.2016.26","volume":"3","author":"JM Banda","year":"2016","unstructured":"Banda JM, Evans L, Vanguri RS, Tatonetti NP, Ryan PB, Shah NH. A curated and standardized adverse drug event resource to accelerate drug safety research. Sci Data. 2016;3(1):1\u201311.","journal-title":"Sci Data."},{"key":"810_CR57","doi-asserted-by":"publisher","unstructured":"Wilson N, Kariisa M, Seth P, Smith H IV, Davis NL. Drug and opioid-involved overdose deaths\u2014United States, 2017\u20132018. MMWR Morb Mortal Wkly Rep. 2020;69(11):290-7. https:\/\/doi.org\/10.15585\/mmwr.mm6911a4.","DOI":"10.15585\/mmwr.mm6911a4"},{"key":"810_CR58","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s40264-014-0259-3","volume":"38","author":"GJ Dal Pan","year":"2015","unstructured":"Dal Pan GJ, Arlett PR. The US Food and Drug Administration-European Medicines Agency collaboration in pharmacovigilance: common objectives and common challenges. Drug Saf. 2015;38:13\u20135.","journal-title":"Drug Saf"},{"key":"810_CR59","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s40264-018-0647-1","volume":"41","author":"R Postigo","year":"2018","unstructured":"Postigo R, Brosch S, Slattery J, van Haren A, Dogn\u00e9 J-M, Kurz X, et al. EudraVigilance medicines safety database: publicly accessible data for research and public health protection. Drug Saf. 2018;41:665\u201375.","journal-title":"Drug Saf"},{"issue":"1","key":"810_CR60","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-068127","volume":"13","author":"Y Guan","year":"2023","unstructured":"Guan Y, Qi Y, Zheng L, Yang J, Zhang M, Zhang Q, et al. Data mining techniques for detecting signals of adverse drug reaction of cardiac therapy drugs based on Jinan adverse event reporting system database: a retrospective study. BMJ Open. 2023;13(1):e068127.","journal-title":"BMJ Open"},{"key":"810_CR61","doi-asserted-by":"publisher","first-page":"125ra31","DOI":"10.1126\/scitranslmed.3003377","volume":"4","author":"NP Tatonetti","year":"2012","unstructured":"Tatonetti NP, Ye P, Daneshjou R, Altman RB. Data-driven prediction of drug effects and interactions. Sci Transl Med. 2012;4:125ra31-ra31.","journal-title":"Sci Transl Med"},{"issue":"25","key":"810_CR62","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000029387","volume":"101","author":"HR Kim","year":"2022","unstructured":"Kim HR, Sung M, Park JA, Jeong K, Kim HH, Lee S, et al. Analyzing adverse drug reaction using statistical and machine learning methods: a systematic review. Medicine (Baltimore). 2022;101(25):e29387.","journal-title":"Medicine (Baltimore)"},{"key":"810_CR63","doi-asserted-by":"publisher","first-page":"1323057","DOI":"10.3389\/fdsfr.2023.1323057","volume":"3","author":"PM Cutroneo","year":"2024","unstructured":"Cutroneo PM, Sartori D, Tuccori M, Crisafulli S, Battini V, Carnovale C, et al. Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems. Front Drug Saf Regul. 2024;3:1323057.","journal-title":"Front Drug Saf Regul."},{"key":"810_CR64","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s40264-014-0150-2","volume":"37","author":"K Hoffman","year":"2014","unstructured":"Hoffman K, Dimbil M, Erdman CB, Tatonetti NP, Overstreet BM. The Weber effect and the United States Food and Drug Administration\u2019s Adverse Event Reporting System (FAERS): analysis of sixty-two drugs approved from 2006 to 2010. Drug Saf. 2014;37:283\u201394.","journal-title":"Drug Saf"},{"key":"810_CR65","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/cpt.1481","volume":"106","author":"SK Quinney","year":"2019","unstructured":"Quinney SK. Opportunities and challenges of using big data to detect drug-drug interaction risk. Clin Pharmacol Ther. 2019;106:72\u20134.","journal-title":"Clin Pharmacol Ther"},{"key":"810_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.aichem.2023.100011","author":"S Yang","year":"2023","unstructured":"Yang S, Kar S. Application of artificial intelligence and machine learning in early detection of adverse drug reactions (ADRs) and drug-induced toxicity. Artif Intell Chem. 2023. https:\/\/doi.org\/10.1016\/j.aichem.2023.100011.","journal-title":"Artif Intell Chem"},{"issue":"8","key":"810_CR67","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.217","volume":"1","author":"S Kim","year":"2021","unstructured":"Kim S. Exploring chemical information in PubChem. Curr Protoc. 2021;1(8):e217.","journal-title":"Curr Protoc"},{"issue":"D1","key":"810_CR68","doi-asserted-by":"publisher","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","volume":"52","author":"C Knox","year":"2024","unstructured":"Knox C, Wilson M, Klinger CM, Franklin M, Oler E, Wilson A, et al. DrugBank 6.0: the DrugBank knowledgebase for 2024. Nucleic Acids Res. 2024;52(D1):D1265\u201375.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"810_CR69","doi-asserted-by":"publisher","first-page":"D380","DOI":"10.1093\/nar\/gkv1277","volume":"44","author":"D Szklarczyk","year":"2016","unstructured":"Szklarczyk D, Santos A, Von Mering C, Jensen LJ, Bork P, Kuhn M. STITCH 5: augmenting protein\u2013chemical interaction networks with tissue and affinity data. Nucleic Acids Res. 2016;44(D1):D380\u20134.","journal-title":"Nucleic Acids Res"},{"key":"810_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2018.1","author":"D Demner-Fushman","year":"2018","unstructured":"Demner-Fushman D, Shooshan SE, Rodriguez LM, Aronson AR, Lang F-M, Rogers WJ, et al. A dataset of 200 structured product labels annotated for adverse drug reactions. Sci Data. 2018. https:\/\/doi.org\/10.1038\/sdata.2018.1.","journal-title":"Sci Data"},{"key":"810_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/app11062663","author":"Z Shen","year":"2021","unstructured":"Shen Z, Spruit MR. Automatic extraction of adverse drug reactions from summary of product characteristics. Appl Sci. 2021. https:\/\/doi.org\/10.3390\/app11062663.","journal-title":"Appl Sci"},{"issue":"1","key":"810_CR72","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/pro.4172","volume":"31","author":"M Kanehisa","year":"2022","unstructured":"Kanehisa M, Sato Y, Kawashima M. KEGG mapping tools for uncovering hidden features in biological data. Protein Sci. 2022;31(1):47\u201353.","journal-title":"Protein Sci"},{"issue":"D1","key":"810_CR73","doi-asserted-by":"publisher","first-page":"D1137","DOI":"10.1093\/nar\/gkx1088","volume":"46","author":"VB Siramshetty","year":"2018","unstructured":"Siramshetty VB, Eckert OA, Gohlke B-O, Goede A, Chen Q, Devarakonda P, et al. SuperDRUG2: a one stop resource for approved\/marketed drugs. Nucleic Acids Res. 2018;46(D1):D1137\u201343.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"810_CR74","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.226","volume":"1","author":"L Gong","year":"2021","unstructured":"Gong L, Whirl\u2010Carrillo M, Klein TE. PharmGKB, an integrated resource of pharmacogenomic knowledge. Curr Protoc. 2021;1(8):e226.","journal-title":"Curr Protoc"},{"issue":"5","key":"810_CR75","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.jbi.2008.03.004","volume":"41","author":"F Belleau","year":"2008","unstructured":"Belleau F, Nolin M-A, Tourigny N, Rigault P, Morissette J. Bio2RDF: towards a mashup to build bioinformatics knowledge systems. J Biomed Inform. 2008;41(5):706\u201316.","journal-title":"J Biomed Inform"},{"key":"810_CR76","doi-asserted-by":"crossref","unstructured":"Lee K, Qadir A, Hasan SA, Datla V, Prakash A, Liu J, Farri O, editors. Adverse drug event detection in tweets with semi-supervised convolutional neural networks. In: Proceedings of the 26th International Conference on World Wide Web; 2017.","DOI":"10.1145\/3038912.3052671"},{"key":"810_CR77","unstructured":"Emadzadeh E, Sarker A, Nikfarjam A, Gonzalez G, editors. Hybrid semantic analysis for mapping adverse drug reaction mentions in tweets to medical terminology. In: AMIA Annual Symposium Proceedings; 2017: American Medical Informatics Association."},{"key":"810_CR78","doi-asserted-by":"publisher","unstructured":"Ribeiro LAPA, Cinalli D, Garcia ACB. Discovering adverse drug reactions from Twitter: a sentiment analysis perspective. In: 2021 IEEE 24th International Conference on Computer Supported Cooperative Work in Design (CSCWD); 2021; Dalian, China. p. 1172\u20137. https:\/\/doi.org\/10.1109\/CSCWD49262.2021.9437783.","DOI":"10.1109\/CSCWD49262.2021.9437783"},{"key":"810_CR79","doi-asserted-by":"publisher","first-page":"1645823","DOI":"10.3389\/fcvm.2025.1645823","volume":"12","author":"L Sen","year":"2025","unstructured":"Sen L, Kangpin X, Yihui L. Research progress on bleeding risk assessment models in anticoagulant therapy. Front Cardiovasc Med. 2025;12:1645823.","journal-title":"Front Cardiovasc Med."},{"key":"810_CR80","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.amjcard.2025.02.030","volume":"244","author":"R Chaudhary","year":"2025","unstructured":"Chaudhary R, Nourelahi M, Thoma FW, Gellad WF, Lo-Ciganic W-H, Chaudhary R, et al. Machine learning predicts bleeding risk in atrial fibrillation patients on direct oral anticoagulant. Am J Cardiol. 2025;244:58\u201366.","journal-title":"Am J Cardiol"},{"issue":"1","key":"810_CR81","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12911-023-02274-5","volume":"23","author":"D Chen","year":"2023","unstructured":"Chen D, Wang R, Jiang Y, Xing Z, Sheng Q, Liu X, et al. Application of artificial neural network in daily prediction of bleeding in ICU patients treated with anti-thrombotic therapy. BMC Med Inform Decis Mak. 2023;23(1):171.","journal-title":"BMC Med Inform Decis Mak"},{"key":"810_CR82","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0205872","author":"Z Ma","year":"2018","unstructured":"Ma Z, Wang P, Gao Z, Wang R, Khalighi K. Ensemble of machine learning algorithms using the stacked generalization approach to estimate the warfarin dose. PLoS ONE. 2018. https:\/\/doi.org\/10.1371\/journal.pone.0205872.","journal-title":"PLoS ONE"},{"key":"810_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.911987","volume":"9","author":"WT Liu","year":"2022","unstructured":"Liu WT, Liu XQ, Jiang TT, Wang MY, Huang Y, Huang YL, et al. Using a machine learning model to predict the development of acute kidney injury in patients with heart failure. Front Cardiovasc Med. 2022;9:911987.","journal-title":"Front Cardiovasc Med."},{"issue":"4","key":"810_CR84","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1177\/1074248421995348","volume":"26","author":"ST Simon","year":"2021","unstructured":"Simon ST, Mandair D, Tiwari P, Rosenberg MA. Prediction of drug-induced long QT syndrome using machine learning applied to harmonized electronic health record data. J Cardiovasc Pharmacol Ther. 2021;26(4):335\u201340.","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"5","key":"810_CR85","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.jacep.2024.01.022","volume":"10","author":"H Zhang","year":"2024","unstructured":"Zhang H, Tarabanis C, Jethani N, Goldstein M, Smith S, Chinitz L, et al. QTNet: predicting drug-induced QT prolongation with artificial intelligence-enabled electrocardiograms. JACC Clin Electrophysiol. 2024;10(5):956\u201366.","journal-title":"JACC Clin Electrophysiol."},{"key":"810_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2025.10.045","author":"L Jing","year":"2025","unstructured":"Jing L, Morland TB, Kelsey CR, Raghunath S, Pfeifer JM, Ruhl JA, et al. Machine learning-enabled assessment of risk of drug-induced QT prolongation at the time of prescribing. Heart Rhythm. 2025. https:\/\/doi.org\/10.1016\/j.hrthm.2025.10.045.","journal-title":"Heart Rhythm"},{"issue":"38","key":"810_CR87","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.1093\/eurheartj\/ehab588","volume":"42","author":"E Prifti","year":"2021","unstructured":"Prifti E, Fall A, Davogustto G, Pulini A, Denjoy I, Funck-Brentano C, et al. Deep learning analysis of electrocardiogram for risk prediction of drug-induced arrhythmias and diagnosis of long QT syndrome. Eur Heart J. 2021;42(38):3948\u201361.","journal-title":"Eur Heart J"},{"issue":"1","key":"810_CR88","doi-asserted-by":"publisher","first-page":"2209336","DOI":"10.1080\/07853890.2023.2209336","volume":"55","author":"Z Lin","year":"2023","unstructured":"Lin Z, Cheng YT, Cheung BMY. Machine learning algorithms identify hypokalaemia risk in people with hypertension in the United States National Health and Nutrition Examination Survey 1999\u20132018. Ann Med. 2023;55(1):2209336.","journal-title":"Ann Med"},{"key":"810_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.mex.2025.103460","volume":"15","author":"DB Khemani","year":"2025","unstructured":"Khemani DB, Malave DS, Shinde S, Shukla M, Shikalgar R, Talwar H. AI-driven pharmacovigilance: enhancing adverse drug reaction detection with deep learning and NLP. MethodsX. 2025;15:103460.","journal-title":"MethodsX"},{"key":"810_CR90","doi-asserted-by":"crossref","unstructured":"Sivasubramaniam S, Muniasamy K, L. E, Pradeep S, D. R, S. Y, et al. Research landscape of precision medicine in cardiology. Bioinformation. 2025;21:1886\u201390.","DOI":"10.6026\/973206300211886"},{"key":"810_CR91","doi-asserted-by":"publisher","unstructured":"Li X, Yue X, Zhang L, Zheng X, Shang N. Pharmacist-led surgical medicines prescription optimization and prediction service improves patient outcomes - a machine learning based study. Front Pharmacol. 2025;16:1534552. https:\/\/doi.org\/10.3389\/fphar.2025.1534552.","DOI":"10.3389\/fphar.2025.1534552"},{"issue":"12","key":"810_CR92","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.ijmedinf.2014.08.006","volume":"83","author":"J Lee","year":"2014","unstructured":"Lee J, Han H, Ock M, Lee S-i, Lee S, Jo M-W. Impact of a clinical decision support system for high-alert medications on the prevention of prescription errors. Int J Med Inform. 2014;83(12):929\u201340.","journal-title":"Int J Med Inform"},{"key":"810_CR93","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/BF00561673","volume":"17","author":"M Levy","year":"1980","unstructured":"Levy M, Kewitz H, Altwein W, Hillebrand J, Eliakim M. Hospital admissions due to adverse drug reactions: a comparative study from Jerusalem and Berlin. Eur J Clin Pharmacol. 1980;17:25\u201331.","journal-title":"Eur J Clin Pharmacol"},{"issue":"17","key":"810_CR94","doi-asserted-by":"publisher","first-page":"5798","DOI":"10.3390\/app10175798","volume":"10","author":"C-T Tai","year":"2020","unstructured":"Tai C-T, Sue K-L, Hu Y-H. Machine learning in high-alert medication treatment: a study on the cardiovascular drug. Appl Sci. 2020;10(17):5798.","journal-title":"Appl Sci"},{"key":"810_CR95","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s40261-019-00850-0","volume":"40","author":"Q Li","year":"2020","unstructured":"Li Q, Wang J, Tao H, Zhou Q, Chen J, Fu B, et al. The prediction model of warfarin individual maintenance dose for patients undergoing heart valve replacement, based on the back propagation neural network. Clin Drug Investig. 2020;40:41\u201353.","journal-title":"Clin Drug Investig"},{"issue":"10","key":"810_CR96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0205872","volume":"13","author":"Z Ma","year":"2018","unstructured":"Ma Z, Wang P, Gao Z, Wang R, Khalighi K. Ensemble of machine learning algorithms using the stacked generalization approach to estimate the warfarin dose. PLoS ONE. 2018;13(10):e0205872.","journal-title":"PLoS ONE"},{"issue":"1","key":"810_CR97","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1109\/JBHI.2018.2812165","volume":"23","author":"Y Tao","year":"2018","unstructured":"Tao Y, Chen YJ, Fu X, Jiang B, Zhang Y. Evolutionary ensemble learning algorithm to modeling of warfarin dose prediction for Chinese. IEEE J Biomed Health Inform. 2018;23(1):395\u2013406.","journal-title":"IEEE J Biomed Health Inform"},{"key":"810_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12893-018-0343-1","volume":"18","author":"H Tao","year":"2018","unstructured":"Tao H, Li Q, Zhou Q, Chen J, Fu B, Wang J, et al. A prediction study of warfarin individual stable dose after mechanical heart valve replacement: adaptive neural-fuzzy inference system prediction. BMC Surg. 2018;18:1\u201310.","journal-title":"BMC Surg"},{"key":"810_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2024.104621","volume":"152","author":"Y Li","year":"2024","unstructured":"Li Y, Tao W, Li Z, Sun Z, Li F, Fenton S, et al. Artificial intelligence-powered pharmacovigilance: a review of machine and deep learning in clinical text-based adverse drug event detection for benchmark datasets. J Biomed Inform. 2024;152:104621.","journal-title":"J Biomed Inform"},{"issue":"3","key":"810_CR100","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jaccao.2025.03.004","volume":"7","author":"J Al-Mondhiry","year":"2025","unstructured":"Al-Mondhiry J, Barac A. Immune checkpoint inhibitor-related myocarditis, myopathy, and more: unraveling the tangled science of immune-related adverse events. JACC CardioOncol. 2025;7(3):265\u20137.","journal-title":"JACC CardioOncol."},{"issue":"5","key":"810_CR101","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s10840-022-01400-z","volume":"66","author":"M Fazal","year":"2023","unstructured":"Fazal M, Wei C, Chuy KL, Hussain K, Gomez SE, Ba SS, et al. Tyrosine kinase inhibitor-associated ventricular arrhythmias: a case series and review of literature. J Interv Card Electrophysiol. 2023;66(5):1165\u201375.","journal-title":"J Interv Card Electrophysiol"},{"issue":"1","key":"810_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.medp.2025.100074","volume":"2","author":"G Ling","year":"2025","unstructured":"Ling G, Ge F, Li W, Wei Y, Guo S, Zhang Y, et al. Anthracycline-induced cardiotoxicity: emerging mechanisms and therapies. Med Plus. 2025;2(1):100074.","journal-title":"Med Plus"},{"issue":"Suppl 1","key":"810_CR103","doi-asserted-by":"publisher","first-page":"e14370","DOI":"10.1111\/eci.14370","volume":"55","author":"F Ravera","year":"2025","unstructured":"Ravera F, Gilardi N, Ballestrero A, Zoppoli G. Applications, challenges and future directions of artificial intelligence in cardio-oncology. Eur J Clin Invest. 2025;55(Suppl 1):e14370.","journal-title":"Eur J Clin Invest"},{"key":"810_CR104","doi-asserted-by":"publisher","first-page":"204209862093859","DOI":"10.1177\/2042098620938595","volume":"11","author":"M Alomar","year":"2020","unstructured":"Alomar M, Tawfiq AM, Hassan N, Palaian S. Post marketing surveillance of suspected adverse drug reactions through spontaneous reporting: current status, challenges and the future. Ther Adv Drug Saf. 2020;11:2042098620938595.","journal-title":"Ther Adv Drug Saf."},{"issue":"4","key":"810_CR105","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3390\/pharmacy6040108","volume":"6","author":"S Sundaran","year":"2018","unstructured":"Sundaran S, Udayan A, Hareendranath K, Eliyas B, Ganesan B, Hassan A, et al. Study on the classification, causality, preventability and severity of adverse drug reaction using spontaneous reporting system in hospitalized patients. Pharmacy. 2018;6(4):108.","journal-title":"Pharmacy"},{"key":"810_CR106","unstructured":"US Food and Drug Administration, Center for Drug Evaluation and Research. Questions and answers on FDA\u2019s Adverse Event Reporting System (FAERS) [Internet]. Silver Spring (MD): US Food and Drug Administration; 4 June 2018 [cited 21 June 2026]. Available from: https:\/\/www.fda.gov\/drugs\/drug-approvals-and-databases\/fda-adverse-event-reporting-system-faers-database."},{"key":"810_CR107","doi-asserted-by":"publisher","unstructured":"Cutroneo PM, Sartori D, Tuccori M, Crisafulli S, Battini V, Carnovale C, et al. Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems. Front Drug Saf Regul. 2024;3:1323057. https:\/\/doi.org\/10.3389\/fdsfr.2023.1323057.","DOI":"10.3389\/fdsfr.2023.1323057"},{"key":"810_CR108","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1177\/0018578719882323","volume":"56","author":"R Neha","year":"2019","unstructured":"Neha R, Subeesh V, Beulah E, Gouri N, Maheswari E. Existence of notoriety bias in FDA Adverse Event Reporting System Database and its impact on signal strength. Hosp Pharm. 2019;56:152\u20138.","journal-title":"Hosp Pharm"},{"key":"810_CR109","doi-asserted-by":"crossref","unstructured":"Sandberg A, Salminen V, Heinonen S, Siv\u00e9n M, editors. Under-reporting of adverse drug reactions in Finland and healthcare professionals\u2019 perspectives on how to improve reporting. Healthcare; 2022: MDPI.","DOI":"10.3390\/healthcare10061015"},{"issue":"5","key":"810_CR110","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1080\/14740338.2023.2224558","volume":"22","author":"AZ Al Meslamani","year":"2023","unstructured":"Al Meslamani AZ. Underreporting of adverse drug events: a look into the extent, causes, and potential solutions. Expert Opin Drug Saf. 2023;22(5):351\u20134.","journal-title":"Expert Opin Drug Saf"},{"issue":"7","key":"810_CR111","volume":"11","author":"V Zvonarev","year":"2019","unstructured":"Zvonarev V. Takotsubo cardiomyopathy: medical and psychiatric aspects. role of psychotropic medications in the treatment of adults with \u201cbroken heart\u201d syndrome. Cureus. 2019;11(7):e5177.","journal-title":"Cureus"},{"key":"810_CR112","first-page":"29","volume":"7","author":"M Kawabata","year":"2015","unstructured":"Kawabata M, Yokoyama Y, Sasaki T, Tao S, Ihara K, Shirai Y, et al. Severe iatrogenic bradycardia related to the combined use of beta-blocking agents and sodium channel blockers. Clin Pharmacol. 2015;7:29\u201336.","journal-title":"Clin Pharmacol"},{"issue":"1","key":"810_CR113","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1093\/bib\/bbz140","volume":"22","author":"DA Nguyen","year":"2021","unstructured":"Nguyen DA, Nguyen CH, Mamitsuka H. A survey on adverse drug reaction studies: data, tasks and machine learning methods. Brief Bioinform. 2021;22(1):164\u201377.","journal-title":"Brief Bioinform"},{"issue":"13","key":"810_CR114","doi-asserted-by":"publisher","first-page":"i457","DOI":"10.1093\/bioinformatics\/bty294","volume":"34","author":"M Zitnik","year":"2018","unstructured":"Zitnik M, Agrawal M, Leskovec J. Modeling polypharmacy side effects with graph convolutional networks. Bioinformatics. 2018;34(13):i457\u201366.","journal-title":"Bioinformatics"},{"issue":"5","key":"810_CR115","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s40264-022-01170-7","volume":"45","author":"L Liang","year":"2022","unstructured":"Liang L, Hu J, Sun G, Hong N, Wu G, He Y, et al. Artificial intelligence-based pharmacovigilance in the setting of limited resources. Drug Saf. 2022;45(5):511\u20139.","journal-title":"Drug Saf"},{"issue":"3","key":"810_CR116","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1590\/S0066-782X2006001600026","volume":"87","author":"CP Silva","year":"2006","unstructured":"Silva CP, Bacal F, Pires PV, Drager LF, Souza GEC, Fajardo GMG, et al. The importance of amiodarone pulmonary toxicity in the differential diagnosis of a patient with dyspnea awaiting a heart transplant. Arq Bras Cardiol. 2006;87(3):e4-7.","journal-title":"Arq Bras Cardiol"},{"key":"810_CR117","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.smhs.2020.05.001","volume":"2","author":"AG Swavely","year":"2020","unstructured":"Swavely AG, Durstine JL. Anxiety disorders in patients with cardiopulmonary diseases: a brief review. Sports Med Health Sci. 2020;2:72\u20139.","journal-title":"Sports Med Health Sci."},{"issue":"6","key":"810_CR118","doi-asserted-by":"publisher","DOI":"10.2196\/30137","volume":"7","author":"J-Y Lee","year":"2021","unstructured":"Lee J-Y, Lee Y-S, Kim DH, Lee HS, Yang BR, Kim MG. The use of social media in detecting drug safety\u2013related new black box warnings, labeling changes, or withdrawals: scoping review. JMIR Public Health Surveill. 2021;7(6):e30137.","journal-title":"JMIR Public Health Surveill"},{"key":"810_CR119","doi-asserted-by":"publisher","unstructured":"Scholl J. Signal detection in pharmacovigilance: time for a new era?. [Groningen]: University of Groningen, 2022. 125 p. https:\/\/doi.org\/10.33612\/diss.204264948.","DOI":"10.33612\/diss.204264948"},{"key":"810_CR120","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1007\/s40264-018-0699-2","volume":"41","author":"O Caster","year":"2018","unstructured":"Caster O, Dietrich J, K\u00fcrzinger M-L, Lerch M, Maskell S, Nor\u00e9n GN, et al. Assessment of the utility of social media for broad-ranging statistical signal detection in pharmacovigilance: results from the WEB-RADR project. Drug Saf. 2018;41:1355\u201369.","journal-title":"Drug Saf"},{"key":"810_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2023.106848","volume":"158","author":"N Khalid","year":"2023","unstructured":"Khalid N, Qayyum A, Bilal M, Al-Fuqaha A, Qadir J. Privacy-preserving artificial intelligence in healthcare: techniques and applications. Comput Biol Med. 2023;158:106848.","journal-title":"Comput Biol Med"},{"issue":"1","key":"810_CR122","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1186\/s12909-023-04698-z","volume":"23","author":"SA Alowais","year":"2023","unstructured":"Alowais SA, Alghamdi SS, Alsuhebany N, Alqahtani T, Alshaya AI, Almohareb SN, et al. Revolutionizing healthcare: the role of artificial intelligence in clinical practice. BMC Med Educ. 2023;23(1):689.","journal-title":"BMC Med Educ"},{"key":"810_CR123","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare13212811","author":"H Ryu","year":"2025","unstructured":"Ryu H, Lee M, Kim SH, Kim JH, Yang HJ. Federated learning for cardiovascular disease prediction: a comparative review of biosignal- and EHR-based approaches. Healthcare (Basel). 2025. https:\/\/doi.org\/10.3390\/healthcare13212811.","journal-title":"Healthcare (Basel)"},{"key":"810_CR124","unstructured":"Ghazarian A, Zheng J, Rakovski C. Privacy-preserving ecg data analysis with differential privacy: A literature review and a case study. arXiv preprint arXiv:2406.13880. 2024 Jun 19."},{"issue":"6","key":"810_CR125","doi-asserted-by":"publisher","first-page":"788","DOI":"10.4103\/idoj.idoj_543_23","volume":"14","author":"N Yadav","year":"2023","unstructured":"Yadav N, Pandey S, Gupta A, Dudani P, Gupta S, Rangarajan K. Data privacy in healthcare: in the era of artificial intelligence. Indian Dermatol Online J. 2023;14(6):788\u201392.","journal-title":"Indian Dermatol Online J"},{"issue":"1","key":"810_CR126","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s44163-024-00121-8","volume":"4","author":"A Zafar","year":"2024","unstructured":"Zafar A. Balancing the scale: navigating ethical and practical challenges of artificial intelligence (AI) integration in legal practices. Discov Artif Intell. 2024;4(1):27.","journal-title":"Discov Artif Intell."},{"key":"810_CR127","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2024.108289","volume":"254","author":"M Ferdowsi","year":"2024","unstructured":"Ferdowsi M, Hasan MM, Habib W. Responsible AI for cardiovascular disease detection: towards a privacy-preserving and interpretable model. Comput Methods Progr Biomed. 2024;254:108289.","journal-title":"Comput Methods Progr Biomed"},{"issue":"1","key":"810_CR128","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s44325-024-00031-9","volume":"1","author":"A Mihan","year":"2024","unstructured":"Mihan A, Pandey A, Van Spall HGC. Artificial intelligence bias in the prediction and detection of cardiovascular disease. NPJ Cardiovasc Health. 2024;1(1):31.","journal-title":"NPJ Cardiovasc Health"},{"key":"810_CR129","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1080\/14740338.2019.1577818","volume":"18","author":"T Felix","year":"2019","unstructured":"Felix T, Jordan JB, Akers C, Patel B, Drago D. Current state of biologic pharmacovigilance in the European Union: improvements are needed. Expert Opin Drug Saf. 2019;18:231\u201340.","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"810_CR130","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12911-017-0430-8","volume":"17","author":"JS Ancker","year":"2017","unstructured":"Ancker JS, Edwards A, Nosal S, Hauser D, Mauer E, Kaushal R. Effects of workload, work complexity, and repeated alerts on alert fatigue in a clinical decision support system. BMC Med Inform Decis Mak. 2017;17(1):36.","journal-title":"BMC Med Inform Decis Mak"},{"key":"810_CR131","doi-asserted-by":"publisher","unstructured":"Gabrielli D, Prenkaj B, Velardi P, Faralli S. AI on the pulse: real-time health anomaly detection with wearable and ambient intelligence [preprint]. arXiv. 2025 Aug 5. https:\/\/doi.org\/10.48550\/arXiv.2508.03436.","DOI":"10.48550\/arXiv.2508.03436"},{"key":"810_CR132","doi-asserted-by":"crossref","unstructured":"Shen Y, Voisin M, Aliamiri A, Avati A, Hannun AY, Ng A. Ambulatory atrial fibrillation monitoring using wearable photoplethysmography with deep learning. In: Proceedings of the 25th ACM SIGKDD International Conference on Knowledge Discovery & Data Mining. 2018.","DOI":"10.1145\/3292500.3330657"},{"issue":"6","key":"810_CR133","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.sapharm.2025.02.008","volume":"21","author":"VS Dsouza","year":"2025","unstructured":"Dsouza VS, Leyens L, Kurian JR, Brand A, Brand H. Artificial intelligence (AI) in pharmacovigilance: a systematic review on predicting adverse drug reactions (ADR) in hospitalized patients. Res Social Adm Pharm. 2025;21(6):453\u201362.","journal-title":"Res Social Adm Pharm"},{"key":"810_CR134","doi-asserted-by":"publisher","unstructured":"Guo B, Chen C, Jia J, Zheng J, Song Y, Liu T, et al. A prediction model of stable warfarin doses in patients after mechanical heart valve replacement based on a machine learning algorithm. Rev Cardiovasc Med. 2025;26(6):33425. https:\/\/doi.org\/10.31083\/RCM33425.","DOI":"10.31083\/RCM33425"},{"key":"810_CR135","doi-asserted-by":"publisher","DOI":"10.1016\/j.compeleceng.2024.109370","volume":"118","author":"Z Sadeghi","year":"2024","unstructured":"Sadeghi Z, Alizadehsani R, Cifci MA, Kausar S, Rehman R, Mahanta P, et al. A review of explainable artificial intelligence in healthcare. Comput Electr Eng. 2024;118:109370.","journal-title":"Comput Electr Eng"},{"issue":"1","key":"810_CR136","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12911-021-01518-6","volume":"21","author":"E Bresso","year":"2021","unstructured":"Bresso E, Monnin P, Bousquet C, Calvier FE, Ndiaye NC, Petitpain N, et al. Investigating ADR mechanisms with Explainable AI: a feasibility study with knowledge graph mining. BMC Med Inform Decis Mak. 2021;21(1):171.","journal-title":"BMC Med Inform Decis Mak"},{"issue":"1","key":"810_CR137","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s12559-023-10179-8","volume":"16","author":"V Hassija","year":"2024","unstructured":"Hassija V, Chamola V, Mahapatra A, Singal A, Goel D, Huang K, et al. Interpreting black-box models: a review on explainable artificial intelligence. Cogn Comput. 2024;16(1):45\u201374.","journal-title":"Cogn Comput"},{"key":"810_CR138","doi-asserted-by":"publisher","DOI":"10.1016\/j.websem.2023.100806","volume":"79","author":"S Schramm","year":"2023","unstructured":"Schramm S, Wehner C, Schmid U. Comprehensible artificial intelligence on knowledge graphs: a survey. J Web Semant. 2023;79:100806.","journal-title":"J Web Semant."}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-026-00810-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40256-026-00810-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-026-00810-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:02:54Z","timestamp":1787313774000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40256-026-00810-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":138,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["810"],"URL":"https:\/\/doi.org\/10.1007\/s40256-026-00810-y","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"31 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors declare that they have no potential conflicts of interest that might be relevant to the contents of this manuscript.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Erfan Shahabinejad, Fatemeh Soflaei-Shahrbabak, Marzieh Golami Shoa, Aida Azhdarimoghaddam, Mehrdad Mozafar, Pouya Yektaee-Rad, Samar Monajemi, Shayan Ghanouni, Shuhao Qiu, and Mani Khorsand Askari declare that they have no potential conflicts of interest that might be relevant to the contents of this manuscript. All authors have contributed significantly to this work.","order":2,"name":"Ethics","label":"Ethical Declaration","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Data sharing is not applicable to this article as no new data were created or analyzed in this study.","order":4,"name":"Ethics","label":"Data Availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":6,"name":"Ethics","label":"Consent to Publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":7,"name":"Ethics","label":"Code Availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Erfan Shahabinejad and Mani Khorsand Askari conceptualized and designed the review. Erfan Shahabinejad, Fatemeh Soflaei-Shahrbabak, Marzieh Golami Shoa, Aida Azhdarimoghaddam, Mehrdad Mozafar, and Pouya Yektaee-Rad conducted the literature search and contributed to article selection and synthesis. Samar Monajemi, Shayan Ghanouni, and Shuhao Qiu contributed to manuscript drafting and critical intellectual revisions. Erfan Shahabinejad, Fatemeh Soflaei-Shahrbabak, Marzieh Golami Shoa, Aida Azhdarimoghaddam, and Mehrdad Mozafar prepared the original draft. All authors reviewed, edited, and approved the final manuscript. Erfan Shahabinejad and Mani Khorsand Askari supervised the study.","order":8,"name":"Ethics","label":"Author Contributions","group":{"name":"EthicsHeading","label":"Declarations"}}]}}